Endometriosis and infertility.
Conditions
Interventions
Intervention 1: Intervention group: Infertile endometriosis patients and candidates for embryo transfer treated with Differlin 3.75 in three doses with an interval of one month and then 10 weeks later
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Age between 20 and 40 years Having endometriosis based on laparoscopic evidence
Exclusion criteria
Exclusion criteria: presence of severe sperm disorders in the patient's wife based on WHO 2021 criteria congenital or acquired uterine anomalies in the patient Suffering from thrombophilic diseases such as hemophilia Suffering from autoimmune diseases such as lupus The use of hormonal treatments by the individual Taking immunosuppressant drugs by the individual
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: Pregnancy check with beta hCG test two weeks after embryo transfer. Method of measurement: Beta hCG test.;Abortion. Timepoint: Continued pregnancy up to 20 weeks. Method of measurement: Examining the view of a live fetus with ultrasound.;Live birth. Timepoint: Pregnancy with a gestational age of more than 28 weeks. Method of measurement: Examining the live fetus with ultrasound.;Clinical pregnancy. Timepoint: Sonography 6 weeks later beta hCG positive. Method of measurement: Visualization of fetal heart rate by ultrasound.;Ongoing pregnancy. Timepoint: Continued pregnancy up to 12 weeks. Method of measurement: Ultrasound visualization of a live fetus at 12 weeks. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Shiralizadeh
Iran University of Medical Sciences
Outcome results
None listed